dimenhydrinate | Aviamarin tablets 50 mg 5 pcs.
Special Price
$12.88
Regular Price
$23.00
In stock
SKU
BID485202
Release form
Tablets
Tablets
Release form
Tablets
Packaging
5 pcs
Pharmacological action
Blocks histamine H1 receptors and m-cholinergic receptors of the central nervous system.
Inhibits the vestibular apparatus of the inner ear, acting primarily on otoliths, in high doses - on semicircular canals.
The main effect of dimenhydrinate is realized due to the blockade of m-cholinergic receptors.
Has an antiemetic, sedative effect, eliminates dizziness.
Contraindications
Hypersensitivity to dimenhydrinate or other components of the drug, children under 6 years of age, period of breastfeeding.
Use during pregnancy and lactation
Use of the drug during pregnancy is only possible if the expected benefit to the mother outweighs the potential risk to the fetus.
The use of the drug during breastfeeding is contraindicated.
If it is necessary to use the drug, breast-feeding should be discontinued.
Composition
1 tablet contains:
Active ingredient:
dimenhydrinate 50.0 mg
Excipients:
microcrystalline cellulose 40.0 mg,
povidone 4.0 mg,
crospovid 90 mg,
crosppovidone 10 mg ,
silicon dioxide colloidal dioxide (Aerosil) 4.0 mg,
magnesium stearate 2.0 mg.
Dosage and Administration
Inside, before meals. For the prevention of motion sickness, the first dose should be taken 30-60 minutes before the start of movement.
Children aged 6-12 years: 1 / 2-1 tablet (25-50 mg) every 6-8 hours, but not more than 3 tablets (150 mg) within 24 hours.
Adults and children 12 years of age and older: 1-2 tablets (50-100 mg) every 4-6 hours, but not more than 8 tablets (400 mg) within 24 hours.
Side effects
From the central nervous system: very often - dizziness, drowsiness, impaired attention often - general weakness, fatigue, anxiety, nervousness rarely - headache, insomnia.
On the part of the sensory organs: often a weakening of night and color vision, blurred vision, impaired accommodation.
From the digestive system: often - dry mouth, nausea, vomiting is very rare - loss of appetite.
From the respiratory system: infrequently - dryness of the mucous membrane of the nose and throat, thickening of the bronchial secretion.
From the cardiovascular system: rarely - lowering blood pressure, tachycardia.
Allergic reactions: rarely a skin rash, drug dermatitis is very rare - angioedema, bronchospasm.
From the urinary system: rarely - difficulty urinating.
Other: rarely hemolytic anemia.
If any of the adverse reactions listed in the instructions are exacerbated, or you notice any other adverse events not listed in the instructions, notify your doctor.
Drug interaction
Dimenhydrinate enhances the effects of atropine, tricyclic antidepressants, catecholamines, barbiturates, ethanol, sedatives and hypnotics, antipsychotics.
Dimenhydrinate weakens the effect of corticosteroids, anticoagulants.
Dimenhydrinate lowers response to apomorphine.
Dimenhydrinate reduces the depressive effect of acetylcholine on the heart muscle.
The simultaneous administration of dimenhydrinate with bismuth preparations, scopolamine, painkillers and psychotropic drugs increases the likelihood of visual impairment.
The simultaneous use of the drug with ototoxic antibiotics (streptomycin, neomycin, viomycin, amikacin, kanamycin) is not recommended, since dimenhydrinate can mask the symptoms of ototoxicity and contribute to the development of irreversible hearing impairment.
Overdose
Symptoms: dry mouth, nose and throat, redness of the face, slow and difficult breathing, confusion, in children - cramps, hallucinations.
If you experience these symptoms, you should immediately consult a doctor.
Treatment: gastric lavage with a suspension of activated charcoal (20-30 g), saline laxative (10-15 g sodium sulfate), symptomatic therapy, with convulsions in children - phenobarbital (5-6 mg / kg), diazepam.
Active ee substances
dimenhydrinate
dosage form
tablets
Indications
Morskaya disease, disease Meniere
Tablets
Packaging
5 pcs
Pharmacological action
Blocks histamine H1 receptors and m-cholinergic receptors of the central nervous system.
Inhibits the vestibular apparatus of the inner ear, acting primarily on otoliths, in high doses - on semicircular canals.
The main effect of dimenhydrinate is realized due to the blockade of m-cholinergic receptors.
Has an antiemetic, sedative effect, eliminates dizziness.
Contraindications
Hypersensitivity to dimenhydrinate or other components of the drug, children under 6 years of age, period of breastfeeding.
Use during pregnancy and lactation
Use of the drug during pregnancy is only possible if the expected benefit to the mother outweighs the potential risk to the fetus.
The use of the drug during breastfeeding is contraindicated.
If it is necessary to use the drug, breast-feeding should be discontinued.
Composition
1 tablet contains:
Active ingredient:
dimenhydrinate 50.0 mg
Excipients:
microcrystalline cellulose 40.0 mg,
povidone 4.0 mg,
crospovid 90 mg,
crosppovidone 10 mg ,
silicon dioxide colloidal dioxide (Aerosil) 4.0 mg,
magnesium stearate 2.0 mg.
Dosage and Administration
Inside, before meals. For the prevention of motion sickness, the first dose should be taken 30-60 minutes before the start of movement.
Children aged 6-12 years: 1 / 2-1 tablet (25-50 mg) every 6-8 hours, but not more than 3 tablets (150 mg) within 24 hours.
Adults and children 12 years of age and older: 1-2 tablets (50-100 mg) every 4-6 hours, but not more than 8 tablets (400 mg) within 24 hours.
Side effects
From the central nervous system: very often - dizziness, drowsiness, impaired attention often - general weakness, fatigue, anxiety, nervousness rarely - headache, insomnia.
On the part of the sensory organs: often a weakening of night and color vision, blurred vision, impaired accommodation.
From the digestive system: often - dry mouth, nausea, vomiting is very rare - loss of appetite.
From the respiratory system: infrequently - dryness of the mucous membrane of the nose and throat, thickening of the bronchial secretion.
From the cardiovascular system: rarely - lowering blood pressure, tachycardia.
Allergic reactions: rarely a skin rash, drug dermatitis is very rare - angioedema, bronchospasm.
From the urinary system: rarely - difficulty urinating.
Other: rarely hemolytic anemia.
If any of the adverse reactions listed in the instructions are exacerbated, or you notice any other adverse events not listed in the instructions, notify your doctor.
Drug interaction
Dimenhydrinate enhances the effects of atropine, tricyclic antidepressants, catecholamines, barbiturates, ethanol, sedatives and hypnotics, antipsychotics.
Dimenhydrinate weakens the effect of corticosteroids, anticoagulants.
Dimenhydrinate lowers response to apomorphine.
Dimenhydrinate reduces the depressive effect of acetylcholine on the heart muscle.
The simultaneous administration of dimenhydrinate with bismuth preparations, scopolamine, painkillers and psychotropic drugs increases the likelihood of visual impairment.
The simultaneous use of the drug with ototoxic antibiotics (streptomycin, neomycin, viomycin, amikacin, kanamycin) is not recommended, since dimenhydrinate can mask the symptoms of ototoxicity and contribute to the development of irreversible hearing impairment.
Overdose
Symptoms: dry mouth, nose and throat, redness of the face, slow and difficult breathing, confusion, in children - cramps, hallucinations.
If you experience these symptoms, you should immediately consult a doctor.
Treatment: gastric lavage with a suspension of activated charcoal (20-30 g), saline laxative (10-15 g sodium sulfate), symptomatic therapy, with convulsions in children - phenobarbital (5-6 mg / kg), diazepam.
Active ee substances
dimenhydrinate
dosage form
tablets
Indications
Morskaya disease, disease Meniere
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review